Gaviscon firm fined15th October 2010
Reckitt Benckiser has agreed to pay a £10.2m fine after admitting to abusing its market position for the supply of heartburn drug Gaviscon.
The Office of Fair Trading (OFT) had accused the household products firm in February of restricting competition in the supply of heartburn medicines to the NHS. The OFT said the fine had been reduced from £12m, reflecting Reckitt's admission and early co-operation with the watchdog but it still remained the highest penalty it had imposed in an abuse-of-dominance case.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Gaviscon firm fined
Author: Mark Nicholls
Article Id: 16401
Date Added: 15th Oct 2010